Fiuzat, M., Ferlin, K., Gottschalk, L., Farb, A., Cavagna, I., Lindenfeld, J., … Heart Failure Collaboratory. (2025). An Innovative Program for Evidence Generation: HFC Perspective on the FDA Total Product Life Cycle Advisory Program. JACC Heart Fail, 13(4), 647–650. https://doi.org/10.1016/j.jchf.2025.01.011

Fiuzat, Mona, Kimberly Ferlin, Laura Gottschalk, Andrew Farb, Isabella Cavagna, JoAnn Lindenfeld, Bram Zuckerman, Douglas Kelly, and Heart Failure Collaboratory. “An Innovative Program for Evidence Generation: HFC Perspective on the FDA Total Product Life Cycle Advisory Program.” JACC Heart Fail 13, no. 4 (April 2025): 647–50. https://doi.org/10.1016/j.jchf.2025.01.011.

Fiuzat M, Ferlin K, Gottschalk L, Farb A, Cavagna I, Lindenfeld J, et al. An Innovative Program for Evidence Generation: HFC Perspective on the FDA Total Product Life Cycle Advisory Program. JACC Heart Fail. 2025 Apr;13(4):647–50.

Fiuzat, Mona, et al. “An Innovative Program for Evidence Generation: HFC Perspective on the FDA Total Product Life Cycle Advisory Program.” JACC Heart Fail, vol. 13, no. 4, Apr. 2025, pp. 647–50. Pubmed, doi:10.1016/j.jchf.2025.01.011.

Fiuzat M, Ferlin K, Gottschalk L, Farb A, Cavagna I, Lindenfeld J, Zuckerman B, Kelly D, Heart Failure Collaboratory. An Innovative Program for Evidence Generation: HFC Perspective on the FDA Total Product Life Cycle Advisory Program. JACC Heart Fail. 2025 Apr;13(4):647–650.